Quest Diagnostics Inc (DGX) income statement
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$259.69+3.34 (+1.30%)
Close on Nov 18, 2026Market cap $28.57BP/E 25.9Yield –
Quest Diagnostics Inc income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 33.1%
- Operating margin
- 14.6%
- Net margin
- 9.5%
- Return on equity, FY2025
- 14.2%
Financial strength
- Current ratio
- 1.70
- Debt to equity
- 0.73
- Debt to assets
- 32.2%
- Cash to current liabilities
- 43.5%
Valuation
- P/E ratio
- 25.9
- Price to sales
- 2.41
- Price to book
- 3.74
- Dividend yield
- –
See a number that looks wrong?